COVID-19 Testing Demand: Increased demand for COVID-19 testing, driven by surges in cases or new variants, typically boosts CODX.US stock price.

Competition: The emergence of new competitors in the COVID-19 testing market or the introduction of more effective or convenient testing methods can negatively impact CODX.US.

Regulatory Changes: Changes in government regulations regarding COVID-19 testing requirements or reimbursement policies can significantly influence the stock price.

Financial Performance: Co-Diagnostics' revenue, earnings, and profitability reports directly impact investor confidence and stock valuation.

Technological Advancements: Innovation in diagnostic technologies, including Co-Diagnostics' own research and development efforts, can affect future growth prospects and stock price.

Market Sentiment: Overall market trends and investor sentiment toward the healthcare sector or diagnostic companies can influence CODX.US's performance.

Global Health Events: Events like pandemics, outbreaks of other infectious diseases, or public health emergencies can indirectly impact the demand for diagnostic solutions and influence the stock.

Supply Chain Disruptions: Disruptions to the supply chain for raw materials or testing kits can hinder Co-Diagnostics' ability to meet demand and negatively impact stock price.

Strategic Partnerships: Collaborations or partnerships with other healthcare companies or government agencies can expand Co-Diagnostics' market reach and positively affect stock value.